Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (611-620 of 738) with videos related to

Pageof 74
Sort By:
BMC Cancer|June 11, 2010
Periostin is up-regulated in high grade and high stage prostate cancerVerena Tischler, Florian R Fritzsche, Peter J Wild, et al.
Neurology|January 26, 2018
Neurofilament light protein in blood predicts regional atrophy in Huntington diseaseEileanoir B Johnson, Lauren M Byrne, Sarah Gregory, et al.
Movement Disorders Clinical Practice|January 24, 2020
Characterizing White Matter in Huntington's DiseaseSarah Gregory, Eileanoir Johnson, Lauren M Byrne, et al.
The Lancet. Neurology|June 18, 2022
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunitiesSarah J Tabrizi, Carlos Estevez-Fraga, Willeke M C van Roon-Mom, et al.
Nature Reviews. Disease Primers|May 19, 2016
Huntington diseaseGillian P Bates, Ray Dorsey, James F Gusella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomyAshkan Mortezavi, Thomas Hermanns, Hans-Helge Seifert, et al.
Scientific Reports|February 11, 2021
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's diseaseZhen-Yi Andy Ou, Lauren M Byrne, Filipe B Rodrigues, et al.
Oncogene|March 14, 2007
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinomaE Dahl, F Wiesmann, M Woenckhaus, et al.
Plos One|August 23, 2011
Brain-derived neurotrophic factor in patients with Huntington's diseaseChiara Zuccato, Manuela Marullo, Barbara Vitali, et al.
Nature Methods|March 4, 2014
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometryCharlotte Giesen, Hao A O Wang, Denis Schapiro, et al.
Pageof 74

Showing results (611-620 of 738) with videos related to

Sort By:
Pageof 74
BMC Cancer|June 11, 2010
Periostin is up-regulated in high grade and high stage prostate cancerVerena Tischler, Florian R Fritzsche, Peter J Wild, et al.
Neurology|January 26, 2018
Neurofilament light protein in blood predicts regional atrophy in Huntington diseaseEileanoir B Johnson, Lauren M Byrne, Sarah Gregory, et al.
Movement Disorders Clinical Practice|January 24, 2020
Characterizing White Matter in Huntington's DiseaseSarah Gregory, Eileanoir Johnson, Lauren M Byrne, et al.
The Lancet. Neurology|June 18, 2022
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunitiesSarah J Tabrizi, Carlos Estevez-Fraga, Willeke M C van Roon-Mom, et al.
Nature Reviews. Disease Primers|May 19, 2016
Huntington diseaseGillian P Bates, Ray Dorsey, James F Gusella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomyAshkan Mortezavi, Thomas Hermanns, Hans-Helge Seifert, et al.
Scientific Reports|February 11, 2021
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's diseaseZhen-Yi Andy Ou, Lauren M Byrne, Filipe B Rodrigues, et al.
Oncogene|March 14, 2007
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinomaE Dahl, F Wiesmann, M Woenckhaus, et al.
Plos One|August 23, 2011
Brain-derived neurotrophic factor in patients with Huntington's diseaseChiara Zuccato, Manuela Marullo, Barbara Vitali, et al.
Nature Methods|March 4, 2014
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometryCharlotte Giesen, Hao A O Wang, Denis Schapiro, et al.
Pageof 74